• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2200071 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2022-03-10 Green Cross China Biological Products Co Ltd view
CYSB2500019 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2025-01-17 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2101131 人免疫球蛋白 human immunoglobulin Injection Biological Products Supplementary Application 2021-08-03 Sichuan Yuanda Shuyang Pharmaceutical Co Ltd view
CYSB2400198 乙型肝炎人免疫球蛋白 human hepatitis B immunoglobulin Injection Biological Products(原15) Supplementary Application 2024-08-07 Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd view
CYSB2400018 狂犬病人免疫球蛋白 human rabies immunoglobulin Injection Biological Products(3.4) Supplementary Application 2024-01-18 Hualan Biological Engineering Chongqing Co Ltd view
CYSB2200238 乙型肝炎人免疫球蛋白 human hepatitis B immunoglobulin Injection Biological Products(原15) Supplementary Application 2022-09-29 Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd view
CXSS2101043 破伤风人免疫球蛋白 human tetanus immunoglobulin Injection Biological Products(3.4) New Drug Application 2021-11-09 Xinjiang Deyuan Biological Engineering Co Ltd view
CXSS2500038 破伤风人免疫球蛋白 human tetanus immunoglobulin Injection Biological Products(3.4) New Drug Application 2025-03-25 Zhejiang Haikang Biotech Products Co Ltd view
CXSS2101003 乙型肝炎人免疫球蛋白 human hepatitis B immunoglobulin Injection Biological Products(3.4) New Drug Application 2021-05-25 Hualan Biological Engineering Chongqing Co Ltd view
CYSB2400270 破伤风人免疫球蛋白 human tetanus immunoglobulin Injection Biological Products Supplementary Application 2024-10-13 Sichuan Yuanda Shuyang Pharmaceutical Co Ltd view
CYSB2400083 人免疫球蛋白 human immunoglobulin Injection Biological Products(原15) Supplementary Application 2024-03-29 Hualan Biological Engineering Inc view
CYSB2101161 狂犬病人免疫球蛋白 human rabies immunoglobulin Injection Biological Products Supplementary Application 2021-08-19 Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd view
CYSB2200066 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2022-03-01 Shenzhen Weiguang Biological Products Co Ltd view
CYSB2500005 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2025-01-04 Yunnan Bohui Innovative Biology Co Ltd view
CYSB2101040 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2021-04-14 Shanxi Kangbao Biological Product Co Ltd view
CYSB2400143 狂犬病人免疫球蛋白 human rabies immunoglobulin Injection Biological Products(3.4) Supplementary Application 2024-06-04 Hualan Biological Engineering Chongqing Co Ltd view
CYSB2300148 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2023-07-28 Xinjiang Deyuan Biological Engineering Co Ltd view
CXSL2200012 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(3.4) New Drug Application 2022-01-12 Guangdong Danxia Biology Pharmcy Co Ltd view
CYSB2200210 狂犬病人免疫球蛋白 human rabies immunoglobulin Injection Biological Products Supplementary Application 2022-08-18 Hualan Biological Engineering Inc view
CYSB2500035 狂犬病人免疫球蛋白 human rabies immunoglobulin Injection Biological Products(原15) Supplementary Application 2025-01-27 Tonrol Bio-Pharmaceutical Co Limited view